Imidazole Ketone Erastin (IKE) Mechanism of Action: SLC7A11 Inhibition in Tumor Cell Research

Imidazole Ketone Erastin (IKE) MOA:Targeting SLC7A11/Ferroptosis Pathway for Oncology

🎯 check Imidazole Ketone Erastin (IKE) product page

Imidazole Ketone Erastin (IKE) is a potent xCT transporter inhibitor. It affects glutathione metabolism and ferroptosis signaling by depleting GSH and elevating lipid peroxidation, effectively promoting ferroptotic cell death in cancer cells.

Primary Applications and Mechanism of Action